Improved early risk stratification with cystatin C-based estimated GFR
- PMID: 24602780
- PMCID: PMC6380357
- DOI: 10.1053/j.ajkd.2014.02.006
Improved early risk stratification with cystatin C-based estimated GFR
Comment on
-
Cystatin C versus creatinine in determining risk based on kidney function.N Engl J Med. 2013 Sep 5;369(10):932-43. doi: 10.1056/NEJMoa1214234. N Engl J Med. 2013. PMID: 24004120 Free PMC article.
References
-
- Ibrahim H, Mondress M, Tello A, Fan Y, Koopmeiners J, Thomas W. An alternative formula to the Cockcroft-Gault and the modification of diet in renal diseases formulas in predicting GFR in individuals with type 1 diabetes. J Am Soc Nephrol. 2005. April;16(4):1051–60 - PubMed
-
- Gaspari F, Ruggenenti P, Porrini E, Motterlini N, Cannata A, Carrara F, Sosa AJ, Cella C, Ferrari S, Stucchi N, Parvanova A, Iliev I, Trevisan R, Bossi A, Zaletel J, Remuzzi G for the GFR Study Investigators. The GFR and GFR decline cannot be accurately estimated in type 2 diabetics. Kidney Int. 2013. July;84(1):164–73 - PubMed
-
- Perrone RD, Madias NE, Levey AS. Serum Creatinine as an Index of Renal Function: New Insights into Old Concepts. Clin Chem 1992;38(10):1933–1953 - PubMed
-
- SBU- Swedish Council on Health Technology Assessment Report: Methods to Estimate and Measure Renal Function (Glomerular Filtration Rate) Report no: 214, 2013 (available at www.sbu.se) - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical